Novo Nordisk's pricing tactics from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of price tag gouging, declaring the stark distinction between U.S. price ranges and people in Europe and copyright. Issues with diabetic retinopathy: Di